HONG KONG
Despite Viagara hitting the stores in Hong Kong, the sale of Chinese medicines has not been affected. The Hong Kong health authorities approved the sale of Viagara in February 1999 and the manufacturer Pfizer rushed it to the local pharmaceuticals. Pharmacist Pat Lee said, "On an average, only three or four people ask for Viagara every day.' That could be partly because men who want Viagara have not been able to get a prescription quickly enough.
Pat says many Chinese men still prefer traditional potency medicines often using animal parts unheard of in western pharmacies, but widely available in Hong Kong, mainland China and Taiwan. One such alternative to Viagara is a mixture of ginseng (a root found in Far East) and dried deer penis to be boiled and the liquid drunk once or twice a week.
Related Content
- Climate vulnerability of East Asia: adaptation in the region can provide global benefits
- Health and economic impacts of antimicrobial resistance in the Western Pacific Region, 2020–2030
- REenergising Asia: assessing renewable electricity readiness among key Asian markets
- Ebbing away: Hong Kong's ivory trade
- Covid-19 one year later: public perceptions about pandemics and their links to nature
- Covid-19 one year later: public perceptions about pandemics and their links to nature